GDF-Medical Products and Capabilities Enhancement Activities
Abstract
The goal of the Medical Products and Capabilities Enhancement is to test, evaluate, and support enhancement of existing medical products and medically-related IT systems within the areas of medical simulation, infectious disease, tactical combat casualty care, military operational medicine, and clinical and rehabilitative medicine. Additionally, funding supports the investigation of clinical intervention outcomes to support, enhance, and improve militarily unique Clinical Practice Guidelines. Program Element 6.7 efforts are short-term, high-impact projects. It is an intramural research program focused on the evaluation of new commercial medical capabilities suitable for theater, the testing of a fielded capability to function in an expanded or altered operationally-relevant environment, and investigating the potential to incorporate emerging medical or non-medical technologies into fielded medical systems. The program structure provides a flexible and responsive mechanism to accomplish these objectives. A solicitation is released annually with two submission deadlines. Civilian and military intramural investigators are eligible to apply. Submitted proposals undergo a two-level review – one technical and one programmatic. A technical assessment of the proposals is solicited from the respective subject matter experts within the Joint Program Committees and the advanced development community. Following this, a programmatic review is performed by senior Service experts representing the science and technology base and advanced development. After the programmatic review, funding recommendations are forwarded to the Director, Research, Development and Acquisition, Defense Health Agency for final approval.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2017
- Source ID
- 377A_0607100DHA_2_0130_PB_2017